3 Results for "

KBP7072

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "KBP7072" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-139554A
Purity:  99.79%
Synonyms: KBP-7072 TFA
Target:  

Bacterial

Research Areas:  

Infection

Zifanocycline (KBP-7072) TFA is an orally active, semi-synthetic aminomethylcycline antibiotic that inhibits the normal function of bacterial ribosomes. Zifanocycline TFA has broad spectrum in vitro antimicrobial activity against Gram-positive and Gram-negative bacteria, including many multidrug-resistant pathogens. Zifanocycline TFA is indicated for the study of acute bacterial skin and skin structure infections, community-acquired bacterial pneumonia, and complicated intra-abdominal infections .
loading...
    loading...
Cat. No.: HY-139554
CAS No.: 1420294-56-9
Synonyms: KBP-7072
Target:  

Antibiotic Bacterial

Research Areas:  

Infection

Zifanocycline (KBP-7072) is a semisynthetic third-generation aminomethylcycline antibiotic that inhibits the normal function of the bacterial ribosome. Zifanocycline exhibits a broad spectrum of in vitro antibacterial activity against Gram-positive and Gram-negative bacteria, including many multidrug-resistant pathogens. Zifanocycline is available in both oral and injectable formulations. Zifanocycline can be used for the research of acute bacterial skin and skin structure infections, community-acquired bacterial pneumonia, and complicated intra-abdominal infections .
loading...
    loading...
Cat. No.: HY-139554AR
Synonyms: KBP-7072 TFA (Standard)
Research Areas:  

Infection

Zifanocycline (TFA) (Standard) is the analytical standard of Zifanocycline (TFA). This product is intended for research and analytical applications. Zifanocycline (KBP-7072) TFA is an orally active, semi-synthetic aminomethylcycline antibiotic that inhibits the normal function of bacterial ribosomes. Zifanocycline TFA has broad spectrum in vitro antimicrobial activity against Gram-positive and Gram-negative bacteria, including many multidrug-resistant pathogens. Zifanocycline TFA is indicated for the study of acute bacterial skin and skin structure infections, community-acquired bacterial pneumonia, and complicated intra-abdominal infections[1][2].
loading...
    loading...